País: Austrália
Língua: inglês
Origem: Department of Health (Therapeutic Goods Administration)
Immunoglobulin - normal; Normal Immunoglobulin
CSL Limited
Medicine Registered
Evogam ® AU CMI 5.00 Page 1 of 7 EVOGAM ® Human Normal Immunoglobulin 16% (16 g/100 mL) solution for subcutaneous administration. Consumer Medicine Information 5 ML AUST R 173315 10 ML AUST R 173323 20 ML AUST R 173324 WHAT IS IN THIS LEAFLET? This leaflet answers some common questions about Evogam ® . It does not contain all the available information. If you require further information about this medicine or your treatment, have any questions, or are not sure about something in this leaflet, consult your doctor. All medicines have benefits and risks. Your doctor has weighed the benefits that Evogam ® will have for you against the possible risks. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR. FOLLOW YOUR DOCTOR’S ADVICE EVEN IF IT IS DIFFERENT FROM WHAT THIS LEAFLET SAYS. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. The information in this leaflet is subject to change. PLEASE CHECK WITH YOUR DOCTOR WHETHER THERE IS ANY NEW INFORMATION ABOUT THIS MEDICINE THAT YOU SHOULD KNOW SINCE YOU WERE LAST TREATED WITH THIS MEDICINE. WHAT EVOGAM ® IS USED FOR Your medicine is Evogam ® , a solution for subcutaneous infusion. Evogam ® contains human immunoglobulins and is prepared from human blood collected by the Australian Red Cross Blood Service. Immunoglobulins are also called antibodies and are a type of protein found in the blood. Immunoglobulins are produced by your body’s immune system to fight infections caused by bacteria and viruses. If you do not have enough antibodies you may not be able to fight off diseases. Evogam ® can be used as antibody replacement therapy, to correct this lack of antibodies. Your doctor may have prescribed Evogam ® for an Leia o documento completo
Evogam AU PI 3.00 Page 1 of 8 PRODUCT INFORMATION EVOGAM ® AUSTRALIA NAME OF THE MEDICINE Human Normal Immunoglobulin 16%_ _(16 g/100 mL), solution for subcutaneous administration. DESCRIPTION Evogam ® is a sterile preservative free solution containing 16 g per 100 mL of total human plasma immunoglobulin with a purity of at least 98% immunoglobulin G (IgG). At least 85% consists of monomers and dimers (typically >90%) and less than <10% of the IgG are aggregates. The distribution of the IgG subclasses closely resembles that found in normal human plasma (approximate ranges for Evogam ® : 47.8-58.1% IgG 1 , 38.8-49.3% IgG 2 , 0.9-1.4% IgG 3 , 1.4-2.1% IgG 4 ). The pH value of the ready-to-use solution is 6.6. Evogam ® contains 2.25 g of glycine in each 100 mL as a stabiliser which is a physiological non-essential amino acid. Evogam ® does not contain a carbohydrate stabiliser (e.g. sucrose, maltose) and contains no preservative. Evogam ® contains only trace amounts of IgA, typically <0.025 mg/mL. Evogam ® is manufactured from human plasma collected by the Australian Red Cross Blood Service. The manufacturing process contains two dedicated steps to reduce the possibility of pathogen transmission: • pasteurisation (60°C for 10 hours) • nanofiltration. PHARMACOLOGY PHARMACODYNAMICS Evogam ® contains the IgG antibodies present in the donor population. It is prepared from pooled plasma collected from not fewer than 1000 donors. It has an IgG subclass distribution closely proportional to normal human plasma. Evogam ® contains functionally intact IgG with a broad spectrum of antibodies against infectious agents. The IgG molecules have not been chemically or enzymatically modified and the Fc and Fab funct Leia o documento completo